Full Editor

Likes	Subject	Older
	Just In: $ALNY Can Either of These Little-Known		whytestocks	10/18/20 7:15 AM
	Vir and Alnylam Identify RNAi Therapeutic Development Candidate,		MinnieM	05/05/20 12:37 AM
	$ALNY short squeeze article https://news.squeezereport.com/short-squ		whytestocks	12/25/19 1:10 PM
	News: $ALNY Alnylam to Webcast Presentations at Upcoming		whytestocks	11/26/19 7:00 PM
	Stock is going to the moon		zerowinner	11/21/19 6:34 AM
	News: $ALNY Alnylam Announces New and Enhanced Framework		whytestocks	11/20/19 6:30 PM
	News: $ALNY Alnylam Announces Approval of GIVLAARI(TM) (givosiran)		whytestocks	11/20/19 5:15 PM
	News: $ALNY Alnylam Initiates ILLUMINATE-C Phase 3 Study		whytestocks	11/09/19 12:15 PM
	Phase 3 data, due in the 3rd quarter		Glider549	07/15/19 8:26 AM
	It's going a bit crazy in the after		MinnieM	08/10/18 5:16 PM
	Agree.		doughboy2	08/10/18 5:12 PM
	It will be interesting to see the following		MinnieM	08/10/18 4:08 PM
	Who would have predicted that ALNY would get		oxnous	01/29/18 7:20 PM
	IMO of course.		FooBarAndGrill	11/23/17 9:27 AM
	IMO of course.		FooBarAndGrill	10/10/17 12:30 PM
	About RNAi		FooBarAndGrill	10/02/17 10:52 AM
	$ALNY Alnylam Pharmaceuticals Inc. https://www.barchart.com/story/stocks		BottomBounce	09/27/17 10:26 PM
	Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi		FooBarAndGrill	09/26/17 3:05 PM
	I've been following developments in RNAI for years.		FooBarAndGrill	09/25/17 2:16 PM
	https://seekingalpha.com/article/4109199-alnylam-sanofi-achieve-rnai-first		Inoviorulez	09/25/17 11:28 AM
	In addition to new data on the Company’s		FooBarAndGrill	09/25/17 11:01 AM
	“At Alnylam, we’ve been successful in advancing our		FooBarAndGrill	09/25/17 11:00 AM
	ESC+ GalNAc conjugates utilize advanced design features to		FooBarAndGrill	09/25/17 11:00 AM
	Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics		FooBarAndGrill	09/25/17 10:58 AM
	Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares jumped more		FooBarAndGrill	09/22/17 12:49 PM
	I am a finance graduate and have always		NewTrader93	09/20/17 3:38 PM
	FANTASTIC SHORT OPP TODAY...		Bernstein	09/20/17 9:58 AM
	https://seekingalpha.com/article/4101274-alnylam-q3-catalysts-play		Inoviorulez	08/23/17 5:32 PM
	https://seekingalpha.com/article/4086761-alnylam-sanofi-produce-monster-alternat		Inoviorulez	07/10/17 4:55 PM
	ALNY buy option 71.49		stocktrademan	05/19/17 1:31 PM
	Back over 40/share by Tuesday. Anyone ready?!		PennyStockC	10/16/16 10:11 PM
	Liking it putting in a new high since		rivervalley	10/10/16 12:14 PM
	Back to over 38 we go today alone. Weeeee		PennyStockC	10/10/16 11:37 AM
	So far hod 36.07, keep it rolling :)		rivervalley	10/10/16 9:34 AM
	Picked up a starter in pm.		rivervalley	10/10/16 8:43 AM
	After hours news prompting investigation... Ffs, I'm flipping hard.		PennyStockC	10/06/16 4:36 PM
	Buyers stepping up now $35.90 after the two		ClarkKant	10/06/16 1:17 PM
	Shorts are in control right now $36.70. Looks		ClarkKant	10/06/16 1:06 PM
	ALNY? Bouncer?		conix	10/06/16 1:04 PM
	Too many shorts now @ $37.50. Will		ClarkKant	10/06/16 12:21 PM
	$36.50 was strong support on the pullback from		ClarkKant	10/06/16 10:58 AM
	$35.80 i want to see $40+!		ClarkKant	10/06/16 10:30 AM
	Watching for a bounce		T695	10/05/16 8:56 PM
	Oversold. I'll be waiting at the bottom either		JTrader	10/05/16 7:03 PM
	lnylam Pharmaceuticals Is About to Compete With One		venturecapp	05/03/16 1:49 PM
	Daily bull flag breakout. HH		2H2	04/21/16 1:38 PM
	$ALNY recent news/filings		stocktrademan	12/03/15 4:18 PM
	The bear case for ALN-PCSsc: #msg-118426765.		DewDiligence	11/11/15 7:13 PM
	It was pretty solid about $40 higher than		jrf30	10/28/15 6:39 PM
	Does anyone BELEIVE that this stock has a		tyhub	10/28/15 6:13 PM
Likes	Subject	Older

Older

whytestocks

10/18/20 7:15 AM

Just In: $ALNY Can Either of These Little-Known

MinnieM

05/05/20 12:37 AM

Vir and Alnylam Identify RNAi Therapeutic Development Candidate,

whytestocks

12/25/19 1:10 PM

$ALNY short squeeze article https://news.squeezereport.com/short-squ

whytestocks

11/26/19 7:00 PM

News: $ALNY Alnylam to Webcast Presentations at Upcoming

zerowinner

11/21/19 6:34 AM

Stock is going to the moon

whytestocks

11/20/19 6:30 PM

News: $ALNY Alnylam Announces New and Enhanced Framework

whytestocks

11/20/19 5:15 PM

News: $ALNY Alnylam Announces Approval of GIVLAARI(TM) (givosiran)

whytestocks

11/09/19 12:15 PM

News: $ALNY Alnylam Initiates ILLUMINATE-C Phase 3 Study

Glider549

07/15/19 8:26 AM

Phase 3 data, due in the 3rd quarter

MinnieM

08/10/18 5:16 PM

It's going a bit crazy in the after

doughboy2

08/10/18 5:12 PM

Agree.

MinnieM

08/10/18 4:08 PM

It will be interesting to see the following

oxnous

01/29/18 7:20 PM

Who would have predicted that ALNY would get

FooBarAndGrill

11/23/17 9:27 AM

IMO of course.

FooBarAndGrill

10/10/17 12:30 PM

IMO of course.

FooBarAndGrill

10/02/17 10:52 AM

About RNAi

BottomBounce

09/27/17 10:26 PM

$ALNY Alnylam Pharmaceuticals Inc. https://www.barchart.com/story/stocks

FooBarAndGrill

09/26/17 3:05 PM

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi

FooBarAndGrill

09/25/17 2:16 PM

I've been following developments in RNAI for years.

Inoviorulez

09/25/17 11:28 AM

https://seekingalpha.com/article/4109199-alnylam-sanofi-achieve-rnai-first

FooBarAndGrill

09/25/17 11:01 AM

In addition to new data on the Company’s

FooBarAndGrill

09/25/17 11:00 AM

“At Alnylam, we’ve been successful in advancing our

FooBarAndGrill

09/25/17 11:00 AM

ESC+ GalNAc conjugates utilize advanced design features to

FooBarAndGrill

09/25/17 10:58 AM

Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics

FooBarAndGrill

09/22/17 12:49 PM

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares jumped more

NewTrader93

09/20/17 3:38 PM

I am a finance graduate and have always

Bernstein

09/20/17 9:58 AM

FANTASTIC SHORT OPP TODAY...

Inoviorulez

08/23/17 5:32 PM

https://seekingalpha.com/article/4101274-alnylam-q3-catalysts-play

Inoviorulez

07/10/17 4:55 PM

https://seekingalpha.com/article/4086761-alnylam-sanofi-produce-monster-alternat

stocktrademan

05/19/17 1:31 PM

ALNY buy option 71.49

PennyStockC

10/16/16 10:11 PM

Back over 40/share by Tuesday. Anyone ready?!

rivervalley

10/10/16 12:14 PM

Liking it putting in a new high since

PennyStockC

10/10/16 11:37 AM

Back to over 38 we go today alone. Weeeee

rivervalley

10/10/16 9:34 AM

So far hod 36.07, keep it rolling :)

rivervalley

10/10/16 8:43 AM

Picked up a starter in pm.

PennyStockC

10/06/16 4:36 PM

After hours news prompting investigation... Ffs, I'm flipping hard.

ClarkKant

10/06/16 1:17 PM

Buyers stepping up now $35.90 after the two

ClarkKant

10/06/16 1:06 PM

Shorts are in control right now $36.70. Looks

conix

10/06/16 1:04 PM

ALNY? Bouncer?

ClarkKant

10/06/16 12:21 PM

Too many shorts now @ $37.50. Will

ClarkKant

10/06/16 10:58 AM

$36.50 was strong support on the pullback from

ClarkKant

10/06/16 10:30 AM

$35.80 i want to see $40+!

T695

10/05/16 8:56 PM

Watching for a bounce

JTrader

10/05/16 7:03 PM

Oversold. I'll be waiting at the bottom either

venturecapp

05/03/16 1:49 PM

lnylam Pharmaceuticals Is About to Compete With One

2H2

04/21/16 1:38 PM

Daily bull flag breakout. HH

stocktrademan

12/03/15 4:18 PM

$ALNY recent news/filings

DewDiligence

11/11/15 7:13 PM

The bear case for ALN-PCSsc: #msg-118426765.

jrf30

10/28/15 6:39 PM

It was pretty solid about $40 higher than

tyhub

10/28/15 6:13 PM

Does anyone BELEIVE that this stock has a

Older

Alnylam Pharmaceuticals Inc. (ALNY)

Followers	15	Posters	50
Posts (Today)	0	Posts (Total)	232
Created	07/09/07	Type	Free
Moderators

http://www.alnylam.com/ http://finance.yahoo.com/q/ks?s=ALNY Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing therapeutics based on RNA interference (RNAi). Its development programs include ALN-RSV01, a phase I human clinical trial product for the treatment of respiratory syncytial virus (RSV) infection; ALN-FLU01 for pandemic influenza; and ALN-PCS01 for the treatment of hypercholesterolemia with an RNAi therapeutic. The company also engages in pre-clinical discovery programs for RNAi therapeutics for the treatment of Parkinson's disease, Huntington's disease, neuropathic pain, progressive multifocal leukoencephalopathy, Ebola virus infection, and cystic fibrosis. It has strategic alliances with Merck & Co., Inc.; Medtronic, Inc.; and Novartis and Biogen Idec, Inc. for the development and commercialization of RNA interference system products. Alnylam also has contracts with government agencies, including the National Institute of Allergy and Infectious Diseases. In addition, it has license agreements with biotechnology companies, which engage in developing RNAi therapeutic products; and research companies that commercialize RNAi reagents or services. Further, the company has collaboration agreements with Medtronic, Inc. for the development of drug-device products to treat diseases caused by degeneration of the nervous system; and Biogen Idec, Inc. for research on the use of RNAi technology to discover and develop therapeutics to treat PML. It also has collaboration agreements with Novartis Pharma AG to develop RNAi therapeutics for pandemic flu; University of Texas Southwestern to develop RNAi therapeutics targeting proprotein convertase subtilisn/kexin type 9; and Inex Pharmaceuticals Corporation for the discovery, development, and commercialization of RNAi therapeutics. The company was founded in 2002 and is based in Cambridge, Massachusetts.